Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hildesheim

Showing results (31-40 of 360) with videos related to

Pageof 36
Sort By:
BMC Infectious Diseases|July 10, 2013
A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa RicaMegan Clarke, Mark Schiffman, Sholom Wacholder, et al.
Lancet (London, England)|October 13, 2009
HPV vaccination in women aged 24-45 yearsDiane Solomon, Phil Castle, Allan Hildesheim, et al.
Vaccine|February 3, 2009
Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et alAllan Hildesheim, Mark Schiffman, Diane Solomon, et al.
The Lancet. Oncology|September 16, 2015
Fewer than three doses of HPV vaccine - Authors' replyAimée R Kreimer, Frank Struyf, Allan Hildesheim, et al.
Journal of Immunological Methods|February 28, 2002
Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responsesJaafar Bennouna, Allan Hildesheim, Kazuaki Chikamatsu, et al.
International Journal of Cancer|September 17, 2019
Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypesMark P Purdue, Qing Lan, Hilde Langseth, et al.
Journal of Immunological Methods|June 2, 2006
DNAse treatment following thawing of cryopreserved PBMC is a procedure suitable for lymphocyte functional studiesAlfonso J García-Piñeres, Allan Hildesheim, Marcus Williams, et al.
Virus Research|November 26, 2002
Past, present, and future of HPV research: highlights from the 19th International Papillomavirus Conference-HPV2001Luisa Lina Villa, Hans-Ulrich Bernard, Martin Kast, et al.
Contemporary Clinical Trials|February 24, 2018
Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccineJoshua N Sampson, Allan Hildesheim, Rolando Herrero, et al.
Molecular and Cellular Probes|January 31, 2012
Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individualsJoseph G Dauner, Yuanji Pan, Allan Hildesheim, et al.
Pageof 36

Showing results (31-40 of 360) with videos related to

Sort By:
Pageof 36
BMC Infectious Diseases|July 10, 2013
A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa RicaMegan Clarke, Mark Schiffman, Sholom Wacholder, et al.
Lancet (London, England)|October 13, 2009
HPV vaccination in women aged 24-45 yearsDiane Solomon, Phil Castle, Allan Hildesheim, et al.
Vaccine|February 3, 2009
Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et alAllan Hildesheim, Mark Schiffman, Diane Solomon, et al.
The Lancet. Oncology|September 16, 2015
Fewer than three doses of HPV vaccine - Authors' replyAimée R Kreimer, Frank Struyf, Allan Hildesheim, et al.
Journal of Immunological Methods|February 28, 2002
Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responsesJaafar Bennouna, Allan Hildesheim, Kazuaki Chikamatsu, et al.
International Journal of Cancer|September 17, 2019
Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypesMark P Purdue, Qing Lan, Hilde Langseth, et al.
Journal of Immunological Methods|June 2, 2006
DNAse treatment following thawing of cryopreserved PBMC is a procedure suitable for lymphocyte functional studiesAlfonso J García-Piñeres, Allan Hildesheim, Marcus Williams, et al.
Virus Research|November 26, 2002
Past, present, and future of HPV research: highlights from the 19th International Papillomavirus Conference-HPV2001Luisa Lina Villa, Hans-Ulrich Bernard, Martin Kast, et al.
Contemporary Clinical Trials|February 24, 2018
Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccineJoshua N Sampson, Allan Hildesheim, Rolando Herrero, et al.
Molecular and Cellular Probes|January 31, 2012
Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individualsJoseph G Dauner, Yuanji Pan, Allan Hildesheim, et al.
Pageof 36